Hormonal modulation of interleukin-6, tumor necrosis factor and associated receptor secretion in postmenopausal women

Cytokine

Volumn 19, Issue 4, 2002, Pages 193-200

  Brooks Asplund, Esther M ^a   Tupper, Carrie E ^a   Daun, Jane M ^a   Kenney, W Larry ^a   Cannon, Joseph G ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Bone turnover; C reactive protein; Estrogen; FSH; Progestin

Indexed keywords

C REACTIVE PROTEIN; ESTROGEN; FOLLITROPIN; GESTAGEN; INTERLEUKIN 6; OSTEOCALCIN; RECEPTOR; TUMOR NECROSIS FACTOR;

ARTICLE; CARDIOVASCULAR RISK; CELL SECRETION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE MARKER; DRUG MECHANISM; ESTROGEN THERAPY; FOLLITROPIN BLOOD LEVEL; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; MONONUCLEAR CELL; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PROTEIN INTERACTION; RISK; SOLUBILITY;

EID: 0036387156     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2002.1963     Document Type: Article

References (38)

1. Avioli LV (1994) Impact of the menopause on skeletal metabolism and osteoporotic syndromes. Exp Gerontol 29:391-415.
2. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E, for the Heart and Estrogen/progesterone Replacement Therapy Study (HERS) Research Group (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280:605-613.
3. Pacifici R, Brown C, Puscheck E, Friedrich E, Slatopolsky E, Maggio D, McCracken R, Avioli LV (1991) Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 88:5134-5138.
4. Pioli G, Basini G, Pedrazzoni M, Musetti G, Ulietti V, Bresciani D, Villa P, Bacchi A, Hughes D, Russell G, Passeri M (1992) Spontaneous release of interleukin-1 and interleukin-6 by peripheral blood mononuclear cells after oophorectomy. Clin Sci 83:503-507.
5. McKane WR, Khosla S, Peterson JM, Egan K, Riggs BL (1994) Circulating levels of cytokines that modulate bone resorption: Effects of age and menopause in women. J Bone Miner Res 9:1313-1318.
6. Stock JL, Coderre JA, McDonald B, Rosenwasser LJ (1989) Effects of estrogen in vivo and in vitro on spontaneous interleukin-1 release by monocytes from postmenopausal women. J Clin Endo Metab 68:364-368.
7. Ishimi Y, Miyaura C, Jin CH, Akutsu T, Abe E, Nakamura Y, Yoshiki S, Matsuda T, Hirano T (1990) IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145:3297-3303.
8. Thomson BM, Mundy GR, Chambers TJ (1987) Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol 138:775-779.
9. Kimble RB, Matayoshi AB, Vannice JL, Kung VT, Williams C, Pacifici R (1995) Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 136:3054-3061.
10. Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, Ciliberto G, Rodan GA, Costantini F (1994) Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 13:1189-1196.
11. Manolagas SC, Jilka RL (1995) Bone marrow, cytokines and bone remodeling. N Engl J Med 332:305-311.
12. Pacifici R (1996) Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11:1043-1051.
13. Hogasen AKM, Nordsletten L, Aasen AO, Falch JA (1995) There is no difference in spontaneous and 17β-estradiol-induced interleukin-1β release by peripheral blood mononuclear cells from nonosteoporotic women with different rates of early postmenopausal bone loss. J Clin Endo Metab 81:513-518.
14. Kassam M, Khosla S, Spelsberg TC, Riggs BL (1996) Cytokine production in the bone marrow microenvironment: Failure to demonstrate estrogen regulation in early postmenopausal women. J Clin Endo Metab 81:513-518.
15. Khosla S, Peterson JM, Egan K, Jones JD, Riggs BL (1994) Circulating cytokine levels in osteoporotic and normal women. J Clin Endo Metab 79:707-711.
16. Nilas L, Christiansen C (1987) Bone mass and its relationship to age and the menopause. J Clin Endo Metab 65: 697-702.
17. Brooks-Asplund EM, Cannon JG, Kenney WL (2000) Influence of hormone replacement therapy and aspirin on temperature regulation in postmenopausal women. Am J Physiol Integr Reg Comp 279:R839-R848.
18. Knapen MHJ, Kruseman APN, Wouters RSME, Vermeer C (1998) Correlation of serum osteocalcin fractions with bone mineral density in women during the first 10 years after menopause. Calc Tiss Intern 63:375-379.
19. Gauldie J, Baumann H (1991) Cytokines and acute phase protein expression. In: Kimball ES (ed.) Cytokines and Inflammation. CRC Press, Boca Raton, pp 275-305.
20. Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836-843.
21. Cannon JG, Angel JB, Ball RW, Abad LW, Fagioli L, Komaroff AL (1999) Acute phase responses and cytokine secretion in chronic fatigue syndrome. J Clin Immunol 19:414-421.
22. Porter VR, Greendale GA, Schocken M, Zhu X, Effros RB (2001) Immune effects of hormone replacement therapy in postmenopausal women. Exp Gerontol 36:311-326.
23. Wise PM (1999) Neuroendocrine modulation of the "menopause": insights into the aging brain. Am J Physiol 277:E965-E970.
24. Besedovsky H, Rey Ad, Sorkin E, Dinarello CA (1986) Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233:652-654.
25. Rogers A, Eastell R (1998) Effects of estrogen therapy of postmenopausal women on cytokines measured in peripheral blood. J Bone Miner Res 13:1577-1586.
26. Li ZG, Danis VA, Brooks PM (1993) Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin Exp Rheumatol 11:157-160.
27. Salkeld BD, MacAuley JC, Ball RW, Cannon JG (2001) Modulation of body temperature, interleukin-6 and leptin by oral contraceptive use. NeuroImmunoModulation 9:319-325.
28. Thabard W, Collette M, Bataille R, Amiot M (2001) Protein kinase C delta and eta isoenzymes control the shedding of the interleukin 6 receptor alpha in myeloma cells. Biochem J 358:193-200.
29. Yee JB, Hutson JC (1985) Biochemical consequences of follicle stimulating hormone binding to testicular macrophages in culture. Biol Reprod 32:872-879.
30. Corwin EJ, Cannon JG (1999) Gonadotropin modulation of interleukin-1 secretion. J Gender-Specific Med 2:30-34.
31. Horowitz MC (1993) Cytokines and estrogen in bone: Anti-osteoporotic effects. Science 260:626-627.
32. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D (1992) Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 175:323-329.
33. Cushman M, Legault C, Barrett-Connor E, Sefanick ML, Kessler C, Judd HL, Sakkinen PA, Tracy RP (1999) Effect of postmenopausal hormones on inflammation-sensitive proteins. Circulation 100:717-722.
34. Ridker PM, Hennekens CH, Rifai N, Buring JE, Manson JE (1999) Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 100:713-717.
35. Torzewski J, Torzewski M, Bowyer DE, Frohlich M, Koenig W, Waltenberger J, Fitzsimmons C, Hombach V (1998) C-reactive protein frequently colocalizes with the terminal conplement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 18:1386-1392.
36. Szalai AJ, Ginkel FWv, Dalrymple SA, Murray R, McGhee JR, Volanakis JE (1998) Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice. J Immunol 160:5294-5299.
37. Simon C, Polan ML (1994) Cytokines and reproduction. West J Med 160:425-429.
38. Macy EM, Hayes TE, Tracy RP (1997) Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 43:52-58.